Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 21561890.
- Also identified by DOI 10.1136/thoraxjnl-2011-200015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
PulMiCC (Pulmonary Metastasectomy in Colorectal Cancer) is a randomised controlled trial funded by Cancer Research UK. Patients with a history of resected colorectal cancer who are found to have pulmonary metastases are first registered for evaluation and, if subsequently eligible for the trial, they are invited to be randomly allocated to 'active monitoring' or 'active monitoring with pulmonary metastasectomy'. The clinical outcomes are overall survival, relapse-free survival, lung function and patient-reported quality of life.
Medical subject headings
- Colorectal Neoplasms
- Lung Neoplasms
- Metastasectomy